IMSR

Terrestrial Energy is a pre-commercial molten-salt reactor developer that came public via a reverse merger with HCM II in October 2025. The numbers are unambiguously those of a science project, not an operating business: FY2024 revenue was $248K and FY2025 revenue is effectively zero, against a $28.0M net loss and $25.2M operating loss (R&D $9.77M, G&A $14.3M — G&A grew 242% YoY as public-company costs hit). The MD&A's own results table confirms revenue went from $248,357 to nil. At $6.86 the market is paying $727M for this, or 2,926x trailing sales — a multiple that only makes sense if you treat the equity as a long-dated call option on IMSR commercialization, not as a claim on cash flows.

What's genuinely changed the picture is the DOE optionality. The MD&A discloses selection into the Advanced Reactor Pilot Program (Aug 2025), the Advanced Nuclear Fuel Line Pilot Project (Sep 2025), and — most importantly — two January 2026 Other Transaction Authority agreements: Project TETRA (a pilot IMSR reactor under EO 14301) and Project TEFLA (a SALEU fuel-salt pilot line). These let the company advance 'from design to operation under DOE authorization outside traditional federal contracting constraints,' which is the closest thing to a real catalyst here. The balance sheet was also recapitalized through the SPAC: $97.2M cash, $295M equity, $7.57M total liabilities (0.03x leverage), and $300M current assets vs. $5.92M current liabilities — so dilution risk is deferred, not gone.